Canocapavir | m-entrepreneurship.com

Product Name :
Canocapavir

Search keywords :
Canocapavir

drugId :
null

Target Vo:
Capsid protein

Target Vo Short Name :
Capsid

Moa_Name:
Capsid protein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Zhimeng Biopharma Inc

Active Company_Name :
Shanghai Zhimeng Biopharma Inc

Active Indication_Name:
Hepatitis B

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PI 3 Kinase p85 alpha Antibody
FOXO3 Antibody
FAK Antibody: FAK Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 119 kDa, targeting to FAK. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts